Cambridge-educated Clive Hyman, 64, told his colleague he had just hit his head on a set of marble steps but was 'feeling ...

Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

A corporate finance director died after tripping on stairs and banging his head while making a work call, an inquest heard.

Blue-chip stocks are from companies that are large, well-established, and financially sound. These companies have strong ...

Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an analysis of PFE stock now.

All eyes are on pharmaceutical giant Pfizer as it prepares to release its fourth-quarter and full-year 2025 financial results on February 3. This report is widely viewed as a critical indicator of the ...

BMS looks forward to pivotal readouts for six assets in 2026, ensuring profits after patent expiries for Opdivo and Eliquis.

The article " 2 Buffett Stocks to Load Up On—And 1 to Ditch " first appeared on MarketBeat.

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) is a leading biopharmaceutical company focused on developing ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026.

Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the ...

Are you ignoring the body’s early warning system? In the world of stroke care, there is a dangerous misconception surrounding ...